Illumina | ILMN - Sales Revenues

Stock Price
127.67
Daily Change
-0.21 -0.16%
Monthly
5.68%
Yearly
65.33%
Q2 Forecast
125.14

Illumina reported $1.16B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Agilent USD 1.8B 63M Dec/2025
Bio Techne USD 295.9M 9.34M Dec/2025
Bio-Rad Laboratories USD 693.2M 40.2M Dec/2025
Boston Scientific USD 5.2B 90M Mar/2026
Bruker USD 977.2M 116.7M Dec/2025
Charles River Laboratories USD 994.2M 5.8M Dec/2025
Danaher USD 5.95B 890M Mar/2026
Dentsply International USD 961M 57M Dec/2025
Edwards Lifesciences USD 1.65B 80M Mar/2026
Illumina USD 1.16B 80M Dec/2025
Intuitive Surgical USD 2.77B 100M Mar/2026
IQVIA Holdings USD 4.36B 260M Dec/2025
Laboratory Of America USD 3.52B 40M Dec/2025
Mettler Toledo International USD 1.13B 100M Dec/2025
Myriad Genetics USD 209.8M 4.1M Dec/2025
OraSure Technologies USD 26.76M 322K Dec/2025
Pacific Biosciences Of California USD 44.64M 6.2M Dec/2025
Quest Diagnostics USD 2.9B 90M Mar/2026
Quidel USD 724M 24M Dec/2025
Repligen USD 197.91M 8.91M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Standard Biotools USD 23.8M 4.24M Dec/2025
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Waters USD 932M 132M Dec/2025